medical news from internet

Wednesday, May 6, 2020

■ Prime Minister Shinzo Abe is pushing a Japanese-made drug, Avigan, as a coronavirus treatment, but there is no solid evidence that the medication is actually effective against Covid-19.

Favipiravir

Medication

Description

Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs, it is a pyrazinecarboxamide derivative. Wikipedia

Formula: C₅H₄FN₃O₂

ChemSpider ID: 431002

Other names: T-705, favipira, favilavir

ATC code: J05AX27 (WHO)

ChemSpider ID: 431002

Molar mass: 157.104 g·mol⁻¹

Web results

Avigan May Cause Birth Defects. Japan's Pushing It for ...

www.nytimes.com › business › japan-avigan-coronavirus

1 day ago - This supposed beacon of hope is an antiviral medicine known as Avigan, and its most vocal proponent is Japan's prime minister, Shinzo Abe. Mr.

Avigan set for approval this month in Japan as coronavirus drug

asia.nikkei.com › Business › Pharmaceuticals › Avigan-...

2 days ago - TOKYO -- Japan looks to approve flu drug Avigan as a coronavirus treatment within the month, Prime Minister Shinzo Abe told reporters ...

Fujifilm tests favipiravir as a COVID-19 treatment - C&EN

cen.acs.org › pharmaceuticals › drug-development › Fu...

Apr 16, 2020 - “Avigan tablets are expected to have efficacy against infection with the new coronavirus in view of its characteristic mechanism of action,” says

Free CME/CE Virtual Conference - St. Louis 6/20/20 - Emerging Challenges in Primary Care

Inbox

Gregg Sherman, MD, NACE Chief Medical Officer info@naceonlinemail.com Unsubscribe

3:51 AM (12 hours ago)

to me

View Web Version

Join us from the Comfort of your Home or Office!

In response to the COVID-19 pandemic, NACE has decided to bring you our Emerging Challenges live, regional events virtually this spring.

St. Louis Area Clinicians

Join us Online!

Saturday, June 20, 2020

8:30 am Central

Earn FREE CME/CE Credits

5.25 AMA PRA Category 1 Credits^TM

AAFP Credit Pending
4.25 AANP Contact Hours, which includes pharmacology hours
1.0 ANCC Contact Hour

CME/CE Topics:

Statin Intolerance and Cardiovascular Risk – Strategies for Improving Outcome

Do the Right Thing for the Right Patient: Individualizing OAB Care

COVID-19 Update

RELIEF: The Changing Landscape of Axial Spondyloarthritis: Current and Emerging Agents for Individualized Treatment

Optimizing Outcomes in Diabetes With GLP-1 Therapy: Case Based Strategies for Long-Term Patient Success

View Program Details, Agenda, Faculty, and More!

Join us Online!

We will recreate the onsite learning experience you are accustomed to in our virtual environment. You will have opportunities to engage with faculty and colleagues online, earn CME/CE credit, and stay up to date on the issues that matter most to you and your patients.

or call us at 1-866-266-6223.

NACE Accreditation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
The National Association for Continuing Education designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

NACE AAFP Approval
*Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.

NACE AANP Approval
National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 4.25 Contact hour(s) of continuing education including pharmacology hours.

Med Learning Group Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

Med Learning Group Credit Designation Statement
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

Med Learning Group Nursing Credit Information
Purpose: This program would be beneficial for nurses involved in treating and managing patients with Axial Spondyloarthritis. CNE Credits: 1.0 ANCC Contact Hour.

Med Learning Group CNE Accreditation Statement
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

National Association for Continuing Education

www.naceonline.com

studying length of virus life while aerosol- leaning heavily toward it living 2-3 hours w/droplets living 3 hours on hard surface. This article covers some: https://www.statnews.com/2020/03/16/coronavirus-can-become-aerosol-doesnt-mean-doomed/ 2 , yet it is from March. There may be newer information by now. Best wishes.

Tuesday, May 5, 2020

May 5, 2020 1:01 pm (IST)

Hepatitis C Drugs May Help Fight Covid-19 | Several drugs approved for the treatment of hepatitis C viral infection have been identified as potential candidates against COVID-19 caused by the SARS-CoV-2 coronavirus, according to a study based on extensive calculations using supercomputer simulations. Researchers from Johannes Gutenberg University Mainz (JGU) in Germany simulated the way that about 42,000 different substances listed in open databases bind to certain proteins of SARS-CoV-2, and thereby inhibit the penetration of the virus into the human body or its multiplication, PTI reports.

Coronavirus Update: Remdesivir Donated to Treat COVID-19

Inbox

WebMD health@messages.webmd.com Unsubscribe

4:09 AM (8 hours ago)

to me

Trouble viewing this email? View as a Webpage

Coronavirus Special

Remdesivir Donated to Treat COVID-19

The company that makes the antiviral drug remdesivir is donating 1.5 million doses this week after the FDA issued an emergency use authorization for the drug to treat hospitalized COVID-19 patients. Get the latest news updates here.

Annual COVID-19 Vaccine May Be Necessary

People will likely need to get a coronavirus vaccine every year, similar to the annual flu shot, says an Oxford University scientist working on a vaccine.
Read More

When Do You Need to Wear a Mask?

As people resume going out in public, many are wondering when they need to wear a mask and when it's safe to go without.
Read More

What Is Contact Tracing and How Does It Work?

As many states begin to open up, experts worry that states lack the ability to do contact tracing to help prevent a second wave of infections.
Read More

FAQs on Food and COVID-19: A Nutritionist Answers

There's a lot of confusion about how to handle food. Here are some of the biggest questions our nutritionist is hearing, and some science-backed answers.
Read More

Preparing for the 'New Normal'

We speak with Tom Frieden, MD and former director of the CDC, about what needs to be done now to try and "box in" the virus and keep it from spreading.
Watch Video

Running Without Risk During the Pandemic

It's good for you to take a run during the coronavirus pandemic -- and safe if you take precautions, an expert says.
Read More